These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Detection times of marijuana metabolites in urine by immunoassay and GC-MS. Huestis MA, Mitchell JM, Cone EJ. J Anal Toxicol; 1995 Oct; 19(6):443-9. PubMed ID: 8926739 [Abstract] [Full Text] [Related]
3. Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans. Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA. Clin Chem; 2003 Jul; 49(7):1114-24. PubMed ID: 12816908 [Abstract] [Full Text] [Related]
4. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples. Holler JM, Bosy TZ, Klette KL, Wiegand R, Jemionek J, Jacobs A. J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301 [Abstract] [Full Text] [Related]
5. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood. Hino Y, Ojanperä I, Rasanen I, Vuori E. Forensic Sci Int; 2003 Jan 28; 131(2-3):148-55. PubMed ID: 12590054 [Abstract] [Full Text] [Related]
6. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens. Tsai LS, ElSohly MA, Tsai SF, Murphy TP, Twarowska B, Salamone SJ. J Anal Toxicol; 2000 Jan 28; 24(8):708-14. PubMed ID: 11110026 [Abstract] [Full Text] [Related]
7. Confirmation of Syva enzyme multiple immunoassay technique (EMIT) d.a.u. and Roche Abuscreen radioimmunoassay (RIA) (125I) urine cannabinoid immunoassays by gas chromatographic/mass spectrometric (GC/MS) and bonded-phase adsorption/thin-layer chromatographic (BPA-TLC) methods. Kogan MJ, Al Razi J, Pierson DJ, Willson NJ. J Forensic Sci; 1986 Apr 28; 31(2):494-500. PubMed ID: 3011956 [Abstract] [Full Text] [Related]
8. Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening. Armbruster DA, Hubster EC, Kaufman MS, Ramon MK. Clin Chem; 1995 Jan 28; 41(1):92-8. PubMed ID: 7813088 [Abstract] [Full Text] [Related]
9. Modification and evaluation of Abuscreen OnLine assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u. Cannabinoid 20. Hailer M, Glienke Y, Schwab IM, von Meyer L. J Anal Toxicol; 1995 Jan 28; 19(2):99-103. PubMed ID: 7769796 [Abstract] [Full Text] [Related]
10. Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay compared for drugs-of-abuse screening. Armbruster DA, Schwarzhoff RH, Hubster EC, Liserio MK. Clin Chem; 1993 Oct 28; 39(10):2137-46. PubMed ID: 8403399 [Abstract] [Full Text] [Related]
11. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results. Crouch DJ, Cheever ML, Andrenyak DM, Kuntz DJ, Loughmiller DL. J Forensic Sci; 1998 Jan 28; 43(1):35-40. PubMed ID: 9456522 [Abstract] [Full Text] [Related]
12. Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability. Dextraze P, Griffiths WC, Camara P, Audette L, Rosner M. Ann Clin Lab Sci; 1989 Jan 28; 19(2):133-8. PubMed ID: 2546480 [Abstract] [Full Text] [Related]
13. Evaluation of immunoassays for cannabinoids in urine. Irving J, Leeb B, Foltz RL, Cook CE, Bursey JT, Willette RE. J Anal Toxicol; 1984 Jan 28; 8(4):192-6. PubMed ID: 6471820 [Abstract] [Full Text] [Related]
14. Analysis of forensic specimens for cannabinoids. I. Comparison of RIA and GC/MS analysis of blood. Moody DE, Rittenhouse LF, Monti KM. J Anal Toxicol; 1992 Jan 28; 16(5):297-301. PubMed ID: 1338217 [Abstract] [Full Text] [Related]
15. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples. Wiegand RF, Klette KL, Stout PR, Gehlhausen JM. J Anal Toxicol; 2002 Oct 28; 26(7):519-23. PubMed ID: 12423010 [Abstract] [Full Text] [Related]
17. Accuracy of common drug screen tests. Schwartz JG, Zollars PR, Okorodudu AO, Carnahan JJ, Wallace JE, Briggs JE. Am J Emerg Med; 1991 Mar 28; 9(2):166-70. PubMed ID: 1994947 [Abstract] [Full Text] [Related]
18. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine. D'Nicuola J, Jones R, Levine B, Smith ML. J Anal Toxicol; 1992 Mar 28; 16(4):211-3. PubMed ID: 1501473 [Abstract] [Full Text] [Related]
19. Development and validation of a high-performance liquid chromatography method for the evaluation of niflumic acid cross-reactivity of two commercial immunoassays for cannabinoids in urine. Kovatsi L, Pouliopoulos A, Papadaki A, Samanidou V, Tsoukali H. J Anal Toxicol; 2010 May 28; 34(4):229-32. PubMed ID: 20465870 [Abstract] [Full Text] [Related]
20. Forensic drug testing for opiates. IV. Analytical sensitivity, specificity, and accuracy of commercial urine opiate immunoassays. Cone EJ, Dickerson S, Paul BD, Mitchell JM. J Anal Toxicol; 1992 May 28; 16(2):72-8. PubMed ID: 1501467 [Abstract] [Full Text] [Related] Page: [Next] [New Search]